Cencora, Inc.
CORAction· NYSE· USD
L'essentiel à retenir
- • Dernier cours : 309,78 $US (cours différé)
- • Variation sur 1 an : +0,39 %
- • Type d'actif : Action
- • Place de cotation : NYSE
- • Devise de cotation : USD
- • Clôture précédente : 300,25 $US
Informations
- Symbole
- COR
- Type
- Action
- Place
- NYSE
- Devise
- USD
- Clôture veille
- 300,25 $US
- Variation 1 an
- +0,39 %
Cencora Elects Robert E. Sanchez to Its Board of Directors
CONSHOHOCKEN, Pa., September 25, 2026--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026.
Yahoo Finance · 25/09/2026 · lire l'article ↗
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027
Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses. Speaking at the Morgan Stanley Global Heal
Yahoo Finance · 21/09/2026 · lire l'article ↗
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens. Chief Executive Offi
Yahoo Finance · 21/09/2026 · lire l'article ↗
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch?
On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion […]
Yahoo Finance · 19/09/2026 · lire l'article ↗
Cencora Tech Chief: AI Is Cutting Some Medical Treatment Decisions in Half
Cencora Global Chief Data and Information Officer Pawan Verma spoke with WSJ Leadership Institute President Alan Murray at the WSJLI Technology Council Summit about how AI is being used in healthcare to speed access to treatment. Verma described a retinal oncology use case in which doctors analyze large volumes of imaging data to determine treatment, saying AI is helping cut a decision process that can take 30 to 90 days roughly in half.
Yahoo Finance · 16/09/2026 · lire l'article ↗
The Realities of Managing Enterprise AI
A panel of CIOs from Indeed, New York Life and Cencora discuss the risks and advantages of enterprise AI, including operational efficiency, financial waste and the need to implement “control towers” for human oversight of consequential decisions.
Yahoo Finance · 15/09/2026 · lire l'article ↗
Titres et résumés fournis par les sources d'origine (flux Yahoo Finance). Cliquez pour lire l'article complet.
Questions fréquentes sur Cencora, Inc.
- Quel est le cours actuel de Cencora, Inc. ?
- Le dernier cours connu de Cencora, Inc. (COR) est de 309,78 $US (cours différé, fourni à titre informatif). Cette page est mise à jour régulièrement.
- Quelle est la performance de Cencora, Inc. sur un an ?
- Sur les 12 derniers mois, Cencora, Inc. (COR) affiche une variation de +0,39 %. Les performances passées ne préjugent pas des performances futures.
- Comment suivre Cencora, Inc. dans mon portefeuille ?
- Créez un compte gratuit sur AssetApp, ajoutez COR à l'un de vos portefeuilles et suivez sa valeur, vos plus-values et son actualité — aux côtés de vos autres actifs.
Actifs similaires
Cencora, Inc. : suivre cet actif
Cencora, Inc. (COR) est une action coté sur NYSE en USD. Avec AssetApp, ajoutez COR à votre portefeuille pour suivre sa valeur, vos gains latents et réalisés, et l'évolution de votre patrimoine — sans dépendre de votre courtier.
Suivre COR gratuitement